FDA removes patient-identifiable RWE requirement for device submissions
The FDA’s change opens the door for RWE gleaned from de-identified data sources to be used for device submissions to the agency.
16 December 2025
16 December 2025
The FDA’s change opens the door for RWE gleaned from de-identified data sources to be used for device submissions to the agency.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.